Summary
- Current Price
- As of today, SGP price is $36.95, up +8.41% on
- Current Price All-Time High
- SGP price is currently -0.47% below its historical high of $37.12 set on
- Market Cap
- SGP current market cap is $1B
- Revenue
- SGP current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for SGP is on
Profile
| Metric | Value |
|---|---|
| Full Name | SpyGlass Pharma, Inc. |
| Ticker | NASDAQ: SGP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | spyglasspharma.com |
| Employees | 76 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $36.95 | |
| Price, 1D Change | +8.41% | |
| $1B | ||
| - | ||
| - | ||
| 1.21 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.19 | ||
| EPS, 1Y Change | -30.51% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.19 | ||
| EPS Estimate | -$2.50 | N/A |
| EPS Est. Change | -109.52% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $36.95 | |
| Price Target | $42.00 | - |
| Price Tgt. Change | +13.68% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$0.91 | - | |
| -$2.03 | -$1.19 | +41.12% | |
| -$2.50 | N/A | -109.52% | |
| -$2.81 | N/A | -135.97% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $36.95 | |
| $24.64 | ||
| $28.04 | ||
| - | ||
| $28.29 | ||
| $2.44 | ||
| 1.21 | ||
| $1.93 | ||
| 79.82 | ||
| 53.59% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$1.19 | ||
| -$612.00K | ||
| - | ||
| -$41.45M | ||
| - | ||
| -$39.87M | ||
| - | ||
| -$40.84M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.02 | ||
| 12.67 | ||
| 12.67 | ||
| - | ||
| - | ||
| 68.36 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 5.32 | ||
| -16.42 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$98.84M | ||
| $107.44M | ||
| $116.33M | ||
| $108.77M | ||
| $10.63M | ||
| $8.58M | ||
| $1.58M | ||
| $0.00 | ||
| $2.70M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $39.87M | ||
| $40.84M | ||
| $612.00K | ||
| $0.00 | ||
| $612.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$32.70M | ||
| -$11.79M | ||
| $124.59M | ||
| $789.00K | ||
| -$33.49M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Raymond James | ||
| HC Wainwright & Co. | ||
| Stifel | ||
| Leerink Partners | ||
| Jefferies | ||
| Citigroup |
Analyst sentiment
Institutional ownership
Screeners with SGP
FAQ
- What is the ticker symbol for SpyGlass Pharma, Inc.?
- The ticker symbol for SpyGlass Pharma, Inc. is NASDAQ:SGP
- Does SpyGlass Pharma, Inc. pay dividends?
- No, SpyGlass Pharma, Inc. does not pay dividends
- What sector is SpyGlass Pharma, Inc. in?
- SpyGlass Pharma, Inc. is in the Healthcare sector
- What industry is SpyGlass Pharma, Inc. in?
- SpyGlass Pharma, Inc. is in the Biotechnology industry
- What country is SpyGlass Pharma, Inc. based in?
- SpyGlass Pharma, Inc. is headquartered in United States
- When did SpyGlass Pharma, Inc. go public?
- SpyGlass Pharma, Inc. initial public offering (IPO) was on February 6, 2026
- Is SpyGlass Pharma, Inc. in the S&P 500?
- No, SpyGlass Pharma, Inc. is not included in the S&P 500 index
- Is SpyGlass Pharma, Inc. in the NASDAQ 100?
- No, SpyGlass Pharma, Inc. is not included in the NASDAQ 100 index
- Is SpyGlass Pharma, Inc. in the Dow Jones?
- No, SpyGlass Pharma, Inc. is not included in the Dow Jones index
- When was SpyGlass Pharma, Inc. last earnings report?
- SpyGlass Pharma, Inc.'s most recent earnings report was on August 6, 2026
- When does SpyGlass Pharma, Inc. report earnings?
- The next expected earnings date for SpyGlass Pharma, Inc. is November 12, 2026
Data Sources & References
- SGP Official Website www.spyglasspharma.com
- SGP Profile on Yahoo Finance finance.yahoo.com/quote/SGP
- SGP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/sgp